Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

July 31, 2028

Conditions
Breast Cancer
Trial Locations (22)

41810570

Daniel Fontes Santos de Teive e Argolo, Salvador

59075740

Danielli de Almeida Matias, Natal

60135285

Márcia Cristina Colares Régis de Araújo, Fortaleza

66035265

Sâmio Pimentel Ferreira, Belém

69057205

William Hiromi Fuzita, Manaus

Unknown

Raphael Luzorio Fernandes, Cachoeiro de Itapemirim

Sabina Bandeira Aleixo, Cachoeiro de Itapemirim

Ruffo de Freitas Junior, Goiânia

Cristina de Deus Anjos Tavares Sampaio, Campo Grande

Luis Eduardo Rosa Zucca, Três Lagoas

Micheline Campos Rezende, Muriaé

Karina Costa Maia Vianna, Curitiba

Sérgio Lunardon Padilha, Curitiba

Tomas Reinert, Caxias do Sul

Rafaela Kirchner Piccoli, Ijuí

Mateus Bongers Alessandretti, Porto Alegre

Charles Alain Cordova Pinto, Lages

Kaique Almeida, São Paulo

Mariana Scaranti, São Paulo

64049-200

Cláudio Rocha, Teresina

08730500

Daniel Grabarz, Mogi das Cruzes

01509-900

Monique Celeste Tavares, São Paulo

All Listed Sponsors
lead

Libbs Farmacêutica LTDA

INDUSTRY